Clinical Trial Update: Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays

View source ↗

Summary

Clinical trial update describing genomic analysis of peritoneal mesothelioma using comparative genomic hybridization (CGH) arrays; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Mesothelioma

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Peritoneal Mesothelioma | Status: COMPLETED